Dynamic contrast-enhanced (DCE) MRI: Clinical Trials

2 trials of Dynamic contrast-enhanced (DCE) MRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1
Phase 21Terminated 1

Follow Dynamic contrast-enhanced (DCE) MRI: new trials by email Literature Review of Dynamic contrast-enhanced (DCE) MRI trials Research Report on Dynamic contrast-enhanced (DCE) MRI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
MRI-guided laser ablation, Doxorubicin, Etoposide - Glioma, Pilocytic Astrocytoma
Phase 2TerminatedWashington University School of Medicine62015-08-142024-11-01
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI - Osteosarcoma, Paget's Disease
Not applicableTerminatedVanderbilt-Ingram Cancer Center62013-03-012017-05-08

Conditions studied

Astrocytoma (1)  ·  Bone Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Oligodendroglioma (1)  ·  Optic Nerve Glioma (1)  ·  Osteitis Deformans (1)  ·  Osteosarcoma (1)  ·  Sarcoma, Ewing (1)

Sponsors

Vanderbilt-Ingram Cancer Center (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)

Top investigators

Andrew Cluster, M.D. (1)  ·  Vicki Keedy, MD (1)

NIH funding

U01CA142565 (1)